Career paths - Working abroad in a rural practice
Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more
News
MIMS Summary: NICE approves Acomplia
29-Jul-08
NICE has issued final guidance on the use of rimonabant (Acomplia) for the treatment of obesity.
Rimonabant is recommended as an adjunct to diet and exercise in adults who are obese (BMI >30kg/m2) or overweight (BMI >27kg/m) and who have had an inadequate response to, are intolerant of or are contraindicated to orlistat and sibutramine.
The guidance also recommends the following:
- Treatment with rimonabant should continue beyond 6 months only if the patient has lost at least 5% of their body weight since starting treatment.
- Treatment should be discontinued if a patient returns to their original weight while on rimonabant.
- Treatment should not be continued beyond 2 years without a formal clinical assessment and discussion of the risks and benefits with the patient.
Quick search - use * for an abbreviated search, eg nico*
Tools
Healthcare Republic Forums
Hottest Topics
Registrar
Professional development - Honing your presentation skills
Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more
Journals club - HPV vaccine
Curriculum statement 5. Healthy people: promoting health and preventing disease. Read more
Latest Clinical Articles
Clinical Review - Renal colic
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
Clinical Review - Stroke
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Sjogren's syndrome
Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more
MIMS Product News
New drug - Intelence
Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more
New drug - Doribax
Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more
Ebixa dosing made easier
Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more
Jobs
Job of the Week
- Full time salaried GP South East England
- Salaried GP
- Salaried GPs South East England
- Part-Time Salaried GP South East England
- GP Positions North West England
- General Practice Placements Central London
- Salaried GP West Midlands
- Part Time Salaried GP South West England
- Salaried Doctor East of England
- Salaried GP North West England
Comments
Only registered users may comment. Log in now or register for a free account.